Products and services

FILE - In this Sept. 10, 2019 file photo, Jack Ma, founder of the Alibaba Group, speaks at the company's 20th-anniversary celebration in Hangzhou in eastern China's Zhejiang province. A survey shows Jack Ma, founder of e-commerce giant Alibaba, held onto his status as China's richest entrepreneur as the coronavirus shutdown propelled demand for online shopping and other services. (Chinatopix via AP, File)
October 20, 2020 - 12:42 am
BEIJING (AP) — Jack Ma, founder of e-commerce giant Alibaba, held onto his status as China’s richest tycoon this year as surging demand for online shopping and other services during the coronavirus pandemic swelled the fortunes of internet entrepreneurs, according to a survey released Tuesday. Ma’s...
Read More
FILE - This Dec. 11, 2019 file photo shows Channing Dungey at The Hollywood Reporter's Women in Entertainment Breakfast Gala in Los Angeles. Dungey has been named chairman, Warner Bros. Television Group, starting her tenure at the studio early next year. The news was announced today by Ann Sarnoff, Chair and CEO, WarnerMedia Studios and Networks Group, to whom she will report. Dungey will succeed Peter Roth who will be stepping down from his Studio responsibilities running the TV Group and its operating divisions in early 2021. (Photo by Jordan Strauss/Invision/AP, File)
October 19, 2020 - 12:56 pm
LOS ANGELES (AP) — Veteran TV industry executive Channing Dungey was named chairman of the Warner Bros. Television Group after tenures at ABC and Netflix in which she shepherded hit series including “Scandal." Dungey, who at ABC in 2016 became the first African American head of a network...
Read More
October 16, 2020 - 3:13 pm
DALLAS (AP) — The staff of the Dallas Morning News voted to unionize Friday, becoming the first newspaper in Texas to do so amid a recent wave of labor organizing at news outlets across the country. The Dallas News Guild announced that employees of the paper and its Spanish-language sister...
Read More
FILE - In this July 17, 2020 file photo, a senior citizen holds the hand of a care coordinator at a Health facility in Miami. Federal health officials on Friday unveiled a plan to get approved coronavirus vaccines to nursing home residents free of cost, with the aid of two national pharmacy chains. No vaccine has yet been approved by the Food and Drug Administration, and the distribution program is contingent on that happening first. (AP Photo/Wilfredo Lee)
Associated Press
October 16, 2020 - 9:24 am
WASHINGTON (AP) — Federal health officials on Friday unveiled a plan to get approved coronavirus vaccines to nursing home residents free of cost, with the aid of two national pharmacy chains. No vaccine has yet been approved by the Food and Drug Administration, and the distribution program is...
Read More
In this Sept. 24, 2020, file photo, an employee manually inspects syringes of the SARS CoV-2 Vaccine for COVID-19 produced by Sinovac at its factory in Beijing. China is rapidly increasing the number of people receiving its experimental coronavirus vaccines, with a city offering one to the general public and a biotech company providing another free to students going abroad. (AP Photo/Ng Han Guan, File)
October 16, 2020 - 3:50 am
TAIPEI, Taiwan (AP) — China is rapidly increasing the number of people receiving its experimental coronavirus vaccines, with a city offering one to the general public and a biotech company providing another free to students going abroad. The city of Jiaxing, south of Shanghai, is offering a vaccine...
Read More
People walk past a Miniso shop at a shopping mall in Beijing, Thursday, Oct. 15, 2020. Miniso, a Chinese discount retailer known for its fashionable but affordable household products, is expected to raise up to $562 million in a U.S. initial public offering in New York. The Guangzhou-based retailer is the latest Chinese company to list in the U.S., amid tensions that have taken U.S.-China relations to their worst level in decades. (AP Photo/Mark Schiefelbein)
October 15, 2020 - 10:22 am
HONG KONG (AP) — Shares of Miniso Group Holding jumped in their first day of trading, while the broader markets were on pace for their third straight loss this week. Miniso, a Chinese discount retailer known for its fashionable but affordable household products, raised $608 million in a U.S...
Read More
This image provided by Regeneron on Wednesday, Oct. 14, 2020, shows a vial of the company's Inmazeb medication. On Wednesday, the U.S. Food and Drug Administration said it has approved the drug for treating Ebola in both adults and children. (Regeneron via AP)
October 14, 2020 - 5:44 pm
U.S. regulators Wednesday approved the first drug for the treatment of Ebola. The Food and Drug Administration OK'd the drug developed by Regeneron Pharmaceuticals for treating adults and children with the Zaire Ebola virus strain, the most deadly of six known types. It typically kills 60% to 90%...
Read More
FILE - In this May 2020 photo provided by Eli Lilly, a researcher tests possible COVID-19 antibodies in a laboratory in Indianapolis. Antibodies are proteins the body makes when an infection occurs; they attach to a virus and help it be eliminated. (David Morrison/Eli Lilly via AP)
October 13, 2020 - 1:36 pm
Independent monitors have paused enrollment in a study testing the COVID-19 antiviral drug remdesivir plus an experimental antibody therapy being developed by Eli Lilly that’s similar to a treatment President Donald Trump recently received. Lilly confirmed Tuesday that the study had been paused “...
Read More
FILE - In this Monday, Sept. 21, 2020, file photo, the Wall Street sign is framed by a giant American flag hanging on the New York Stock Exchange. Stocks are edging lower on Wall Street in early trading, Tuesday, Oct. 13, 2020, as the market cools off following a four-day rally. (AP Photo/Mary Altaffer, File)
October 13, 2020 - 11:53 am
Stocks are moving broadly lower on Wall Street Tuesday, on pace to give up some of their recent gains as earnings reporting season gets underway for big companies. The S&P 500 was down 0.8% in afternoon trading, giving back about half the gains from a day earlier, when another surge by Big Tech...
Read More
FILE - This September 2020 photo provided by Johnson & Johnson shows a single-dose COVID-19 vaccine being developed by the company. A late-stage study of Johnson & Johnson’s COVID-19 vaccine candidate has been paused while the company investigates whether a study participant’s “unexplained illness” is related to the shot, the company announced Monday, Oct. 12, 2020. (Cheryl Gerber/Courtesy of Johnson & Johnson via AP, File)
Associated Press
October 12, 2020 - 7:27 pm
NEW BRUNSWICK, N.J. (AP) — A late-stage study of Johnson & Johnson’s COVID-19 vaccine candidate has been paused while the company investigates whether a study participant’s “unexplained illness” is related to the shot. The company said in a statement Monday evening that illnesses, accidents and...
Read More

Pages